These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 38997648
1. Extrachromosomal circular DNA promotes prostate cancer progression through the FAM84B/CDKN1B/MYC/WWP1 axis. Jin W, Xu Z, Song Y, Chen F. Cell Mol Biol Lett; 2024 Jul 12; 29(1):103. PubMed ID: 38997648 [Abstract] [Full Text] [Related]
4. CUL4B/miR-33b/C-MYC axis promotes prostate cancer progression. Zhao M, Qi M, Li X, Hu J, Zhang J, Jiao M, Bai X, Peng X, Han B. Prostate; 2019 Apr 12; 79(5):480-488. PubMed ID: 30609075 [Abstract] [Full Text] [Related]
6. Upregulation of FAM84B during prostate cancer progression. Wong N, Gu Y, Kapoor A, Lin X, Ojo D, Wei F, Yan J, de Melo J, Major P, Wood G, Aziz T, Cutz JC, Bonert M, Patterson AJ, Tang D. Oncotarget; 2017 Mar 21; 8(12):19218-19235. PubMed ID: 28186973 [Abstract] [Full Text] [Related]
8. GLIPR1 suppresses prostate cancer development through targeted oncoprotein destruction. Li L, Ren C, Yang G, Fattah EA, Goltsov AA, Kim SM, Lee JS, Park S, Demayo FJ, Ittmann MM, Troncoso P, Thompson TC. Cancer Res; 2011 Dec 15; 71(24):7694-704. PubMed ID: 22025562 [Abstract] [Full Text] [Related]
9. [Association of TET2, LMTK2 and FAM84B gene expression with prostate cancer risk in Chinese patients]. Wang NN, Wang JY, Shi XH, Zhang YG, Liu M, Wang X, Hui J, Chen X, Liang SY, Wei D, Yang F, Zhao F, Zhang YH, Yang Z. Zhonghua Zhong Liu Za Zhi; 2013 Apr 15; 35(4):262-7. PubMed ID: 23985253 [Abstract] [Full Text] [Related]
16. Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer. Li Q, Li Z, Wei S, Wang W, Chen Z, Zhang L, Chen L, Li B, Sun G, Xu J, Li Q, Wang L, Xu Z, Xia Y, Zhang D, Xu H, Xu Z. J Exp Clin Cancer Res; 2017 Apr 21; 36(1):59. PubMed ID: 28431583 [Abstract] [Full Text] [Related]
20. Bortezomib prevents oncogenesis and bone metastasis of prostate cancer by inhibiting WWP1, Smurf1 and Smurf2. Wang Z, Wang J, Li X, Xing L, Ding Y, Shi P, Zhang Y, Guo S, Shu X, Shan B. Int J Oncol; 2014 Oct 21; 45(4):1469-78. PubMed ID: 25051198 [Abstract] [Full Text] [Related] Page: [Next] [New Search]